Page last updated: 2024-09-03

mk 0663 and Colorectal Neoplasms

mk 0663 has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bachman, KE; Bonnette, WG; Chen, H; Connolly, PJ; Dallas, S; Diloreto, KA; Dong, Y; Edwards, JP; Evans, DC; Ghosh, A; King, P; Li, X; Liao, D; Pande, V; Patel, S; Pietrak, B; Sensenhauser, C; Shi, Y; Suarez, J; Szewczuk, L; Tian, G; Wang, J; Wilde, T; Zhang, Z	1

Other Studies

1 other study(ies) available for mk 0663 and Colorectal Neoplasms

Article	Year
Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer. Journal of medicinal chemistry, 2021, 08-12, Volume: 64, Issue:15 Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoricoxib; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Structure-Activity Relationship	2021

Article

Year

Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer.

Journal of medicinal chemistry, 2021, 08-12, Volume: 64, Issue:15

Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Etoricoxib; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Structure-Activity Relationship

2021